Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 67

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 67
---
 and maintain regulatory approvals for our products, the success of our products depends upon achieving and maintaining market acceptance. Commercializing products is time-consuming, expensive and unpredictable. Furthermore, the market for products that address unmet medical needs is highly speculative. If we overestimate the market opportunity for any of our products or candidates, or if we are unsuccessful in gaining market share, these factors could have a material adverse effect on our business. There can be no assurance that we will be able to successfully commercialize our products or gain market acceptance for such products, including in new markets. New product candidates that appear promising in development may fail to reach the market or may have only limited or no commercial success. If any of our products fail to gain, or lose, market acceptance, our revenues could be adversely impacted, which in turn could have a material adverse effect on our business. 37 Levels of market acceptance for our products could be impacted by several factors, some of which are not within our control, including, among others:

| ● | safety,                                                                                                  
 efficacy, convenience and cost-effectiveness of our products as compared to products of our competitors; |

| ● | scope                                    
 of approved uses and marketing approval; |

| ● | availability                         
 of patent or regulatory exclusivity; |

| ● | timing                                
 of market approvals and market entry; |

| ● | availability                                  
 of alternative products from our competitors; |

| ● | acceptance                    
 of the price of our products; |

| ● | the                         
 shelf life of our products; |

| ● | effectiveness                                
 of our sales forces and promotional efforts; |

| ● | the                                     
 level of reimbursement of our products; |

| ● | acceptance                                             
 of our products on government and private formularies; |

| ● | ability                                                                                           
 to market our products effectively at the retail level or in the appropriate setting of care; and |

| ● | reputation       
 of our products. |

Unexpected safety, efficacy or other concerns, whether actual or perceived, about our products may arise which could have a material adverse effect on our business and operations. Unexpected safety or efficacy concerns can arise with respect to our products, whether or not scientifically justified. These concerns are especially more likely to arise as our products are used or studied over longer periods of time or used by a wider group of patients, some of whom may be taking other medicines or have additional underlying health problems. Such developments can potentially result in product recalls, withdrawals and/or declining sales, as well as product liability, consumer fraud and/or other claims, any